Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$129,167.00

Elucidating Master Regulators of Colon Cancer Metastasis

FY 2012-13

Summary
Colon cancer remains one of the most common types of cancer and is a leading cause of cancer related deaths worldwide. The vast majority of colon cancer related deaths are due to the spread of colon cancer to other organs (metastasis). Thus, preventing the spread of colon cancer and successfully treating it once it has spread are among the most important aims in colon cancer research. Although we have made some progress in chemotherapy, evidence suggests that the majority of patients undergoing drug therapy experience severe, debilitating, and even lethal adverse side effects that considerably outweigh the benefits. Accordingly, determining specifically what controls the spread of colon cancer is essential and should allow clinicians to deliver the most appropriate therapy and spare patients from ineffective and expensive treatments. To help eradicate colon cancer, it is of paramount significance and the objective of this research proposal to achieve accurate detection of risk of colon cancer spreading and to develop a better understanding of why this happens. I plan to comprehensively characterize regulators of colon cancer metastasis and to subsequently develop novel strategies for colon cancer therapy. This research proposal is primed for success because it is based on a strong foundation of highly innovative preliminary data from analyzing over 240 unique human colon cancer tumors and because my lab and I have the breadth of experience, history of achievement in cancer genomics, and highly original approaches to yield definitive results.
Program
CIHR Fellowship
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
269646
Name
Walsh Logan A
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Elucidating Master Regulators of Colon Cancer Metastasis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$129,167
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell Lines; Chip-Seq; Colon Cancer; Epigenomics; Genomics; Metastasis; Microarray; Mouse Models; Shrna; Transcriptome
Abstract
Colon cancer remains one of the most common types of cancer and is a leading cause of cancer related deaths worldwide. The vast majority of colon cancer related deaths are due to the spread of colon cancer to other organs (metastasis). Thus, preventing the spread of colon cancer and successfully treating it once it has spread are among the most important aims in colon cancer research. Although we have made some progress in chemotherapy, evidence suggests that the majority of patients undergoing drug therapy experience severe, debilitating, and even lethal adverse side effects that considerably outweigh the benefits. Accordingly, determining specifically what controls the spread of colon cancer is essential and should allow clinicians to deliver the most appropriate therapy and spare patients from ineffective and expensive treatments. To help eradicate colon cancer, it is of paramount significance and the objective of this research proposal to achieve accurate detection of risk of colon cancer spreading and to develop a better understanding of why this happens. I plan to comprehensively characterize regulators of colon cancer metastasis and to subsequently develop novel strategies for colon cancer therapy. This research proposal is primed for success because it is based on a strong foundation of highly innovative preliminary data from analyzing over 240 unique human colon cancer tumors and because my lab and I have the breadth of experience, history of achievement in cancer genomics, and highly original approaches to yield definitive results.
Competitiondate
201210
Approvedterm2
2 yrs 7 mths
Pinamesdelim
Walsh, Logan A
Approvedterm
2 ans 7 mois
Cihrcontribution2
~ $129,167~ $0~
Direct Payment - $129,167 Grant (2012-13) | Canada Spends